It is believed that XIAP participates in raising cellular resistance to chemotherapy in ovarian cancer, since miR-519d and miR-149 sensitized ovarian cancers to cisplatin-induced cytotoxicity by suppressing XIAP [56,57]. This evidence concerns the gene XIAP and ovarian carcinoma.